SeraCare Releases NGS Reference Material for Hematologic Malignancies - Clinical Lab Products
Analysis of genetic variants in myeloproliferative neoplasms using a 22-gene next-generation sequencing panel | BMC Medical Genomics | Full Text
As to Myeloid Diseases, Make a Habit of Three Things
Seraseq ctDNA: A Breakthrough QC Technology
혈액암 NGS 검사를 위한 표준물질 – Seraseq Myeloid Reference Materials : 네이버 블로그
Understanding and Clarifying the Complexities of HRD Measurements in Cancer | HiSS Diagnostics
As to Myeloid Diseases, Make a Habit of Three Things
Sample Prep Kits – DMark
SeraCare Announces Industry's First Comprehensive NGS Reference Material for Hematologic Malignancies
Analytic validation and clinical utilization of the comprehensive genomic profiling test, GEM ExTra ® | Oncotarget
The First Comprehensive Myeloid Cancer Reference Materials for NGS Assays
A New Day for Myeloid Genomic Profiling - How NGS Advancements Are Pr…
The use of Seraseq® Oncology controls & NGS validation challenges | Webinare | Technical Resources | HiSS Diagnostics
Sopachem Life Sciences Seracare NGS Reference Materials - Sopachem Life Sciences
Analysis of genetic variants in myeloproliferative neoplasms using a 22-gene next-generation sequencing panel | BMC Medical Genomics | Full Text
PDF) Clinical performance and utility of a comprehensive next-generation sequencing DNA panel for the simultaneous analysis of variants, TMB and MSI for myeloid neoplasms
As to Myeloid Diseases, Make a Habit of Three Things
Clinical Validation of a Myeloid Next-Generation Sequencing Panel for Single-Nucleotide Variants, Insertions/Deletions, and Fusion Genes - The Journal of Molecular Diagnostics
Diagnostic Utility of Gene Fusion Panel to Detect Gene Fusions in Fresh and Formalin-Fixed, Paraffin-Embedded Cancer Specimens - ScienceDirect
혈액암 NGS 검사를 위한 표준물질 – Seraseq Myeloid Reference Materials : 네이버 블로그
Cancers | Free Full-Text | Technical Evaluation of Commercial Mutation Analysis Platforms and Reference Materials for Liquid Biopsy Profiling
A New Day for Myeloid Genomic Profiling - How NGS Advancements Are Pr…
A New Day for Myeloid Genomic Profiling - How NGS Advancements Are Pr…
Jobs with SeraCare Life Sciences, Inc.
Seraseq® Tumor Mutation DNA Mix v2 AF 7 HC | 0710-0095 | Seracare
